ORAMED PHARMACEUTICALS INC. — Form 8-K
Filed September 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Form 8-K filed 2026-09-17 reports Item 5.07 (Submission of Matters to a Vote of Security Holders) with period ending 2026-09-15. The filing contains only metadata and XBRL data files; the actual vote results, proposal details, counterparties, dollar amounts, percentages, and share counts are not disclosed in the accessible text provided.
Why this rating
Routine periodic disclosure with no substantive business information available; cannot assess materiality without vote outcome details.
Extracted items
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.